We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

OCT-Guided Stent Optimization in Complex PCI: OCCUPI Shows Optimization Predicts Markedly Better 1‑Year Outcomes

MedXY Editorial Team•Nov 29, 2025•Cardiology
clinical outcomes

Highlights

– In the OCCUPI trial, 71% (549/773) of OCT‑guided PCI procedures met predefined OCT optimization criteria; optimized procedures had a 1‑year primary event rate of 2.9% versus 9.4% when criteria were not met (HR 0.30, 95% CI 0.16–0.58, P < .001).
– Long lesions and small‑vessel disease were independent predictors of OCT sub‑optimization.
– Key OCT components—adequate stent expansion, minimal malapposition, and absence of major edge dissection—were each strongly associated with improved outcomes.

Background: Why intravascular imaging and optimization matter

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unveiling the Impact of Social Determinants of Health Screening: Insights from an 18-Hospital Network ImplementationThis study evaluates the data quality, variability, and clinical outcomes of inpatient social determinants of health screening across 18 hospitals, revealing important disparities and validating the screening tool&#8217;s clinical relevanceSep 13, 2026Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure: Rethinking WHO Anemia ThresholdsThis review synthesizes current evidence on hemoglobin thresholds in heart failure, highlighting that optimal prognosis is associated with hemoglobin levels higher than WHO anemia cutoffs, with clinical implications for management and iron Aug 29, 2026Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT RegistriesThis article reviews improvements in heart failure management and outcomes in Japan between 2013 and 2019-21, highlighting increased guideline-based therapy use and enhanced post-discharge care leading to reduced mortality and readmission rAug 22, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Exploring the Role of Autoimmune Conditions in Acute Interstitial Pneumonia: Clinical Outcomes and Implications
Autoimmune conditions in acute interstitial pneumonia (AIP) are associated with reduced 90-day mortality and better discharge outcomes, indicating distinct clinical trajectories and opportunities for tailored care.
Aug 20, 2026
Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide StudyThis review synthesizes evidence linking NOAC use to slower cognitive decline and improved clinical outcomes in patients with atrial fibrillation and Alzheimer&#8217;s disease, highlighting advantages over warfarin and non-use.Aug 13, 2026
Revolutionizing Classical Hodgkin Lymphoma Treatment: The Promise of Anti-PD-1 TherapyAnti-PD-1 therapy has transformed classical Hodgkin lymphoma management, demonstrating safety, feasibility, and durable efficacy across treatment settings—from relapsed/refractory disease to frontline therapy.Aug 5, 2026